Draft Toxicological Review of Chloroprene: In Support of the Summary Information in the Integrated Risk Information System (IRIS), 57313-57314 [E9-26692]
Download as PDF
Federal Register / Vol. 74, No. 213 / Thursday, November 5, 2009 / Notices
II. How Can I Get Copies of this
Document and Other Related
Information?
ACTION: Notice of final order on petition
to object to Clean Air Act (Act)
operating permit.
EPA has established a docket for this
action under docket identification (ID)
number EPA–HQ–OPPT–2009–0718.
All documents in the docket are listed
in the docket index available at https://
www.regulations.gov. Although listed in
the index, some information is not
publicly available, e.g., Confidential
Business Information (CBI) or other
information whose disclosure is
restricted by statute. Certain other
material, such as copyrighted material,
will be publicly available only in hard
copy. Publicly available docket
materials are available electronically at
https://www.regulations.gov, or, if only
available in hard copy, at the OPPT
Docket. The OPPT Docket is located in
the EPA Docket Center (EPA/DC) at Rm.
3334, EPA West Bldg., 1301
Constitution Ave., NW., Washington,
DC. The EPA/DC Public Reading Room
hours of operation are 8:30 a.m. to 4:30
p.m., Monday through Friday, excluding
legal holidays. The telephone number of
the EPA/DC Public Reading Room is
(202) 566–1744, and the telephone
number for the OPPT Docket is (202)
566–0280. Docket visitors are required
to show photographic identification,
pass through a metal detector, and sign
the EPA visitor log. All visitor bags are
processed through an X-ray machine
and subject to search. Visitors will be
provided an EPA/DC badge that must be
visible at all times in the building and
returned upon departure.
SUMMARY: This document announces
that the EPA Administrator has
responded to a petition asking EPA to
object to an operating permit issued by
the Wisconsin Department of Natural
Resources (WDNR). Specifically, the
Administrator granted in part and
denied in part the petition submitted by
the Sierra Club to object to the operating
permit for Columbia Generating Station
(Columbia).
Pursuant to sections 307(b) and
505(b)(2) of the Act, a petition for
judicial review of those portions of the
petition which EPA denied may be filed
in the United States Court of Appeals
for the appropriate circuit. Any petition
for review shall be filed within 60 days
from the date this notice appears in the
Federal Register, pursuant to section
307 of the Act.
ADDRESSES: You may review copies of
the final order, the petition, and other
supporting information at the EPA
Region 5 Office, 77 West Jackson
Boulevard, Chicago, Illinois 60604. If
you wish to examine these documents,
you should make an appointment at
least 24 hours before visiting day.
Additionally, the final order for the
Columbia petition is available
electronically at: https://www.epa.gov/
region07/programs/artd/air/title5/
petitiondb/petitiondb.htm.
FOR FURTHER INFORMATION CONTACT:
Pamela Blakley, Chief, Air Permits
Section, Air Programs Branch, Air and
Radiation Division, EPA, Region 5, 77
West Jackson Boulevard, Chicago,
Illinois 60604, telephone (312) 886–
4447.
List of Subjects
Environmental protection, Acute
exposure guideline levels,
Administrative practice and procedure,
Hazardous substances, Health and
safety.
Dated: October 28, 2009.
Stephen A. Owens,
Assistant Administrator, Office of Prevention,
Pesticides and Toxic Substances.
[FR Doc. E9–26704 Filed 11–4–09; 8:45 am]
BILLING CODE 6560–50–S
ENVIRONMENTAL PROTECTION
AGENCY
erowe on DSK5CLS3C1PROD with NOTICES
[Regional Docket Nos. V–2008–1, FRL–
8978–1]
Clean Air Act Operating Permit
Program; Petition for Objection to
State Operating Permit for Columbia
Generating Station
AGENCY: Environmental Protection
Agency (EPA).
VerDate Nov<24>2008
14:57 Nov 04, 2009
Jkt 220001
The Act
affords EPA a 45-day period to review,
and object, as appropriate, to Title V
operating permits proposed by state
permitting authorities. Section 505(b)(2)
of the Act authorizes any person to
petition the EPA Administrator within
60 days after the expiration of the EPA
review period to object to a Title V
operating permit if EPA has not done so.
A petition must be based only on
objections to the permit that were raised
with reasonable specificity during the
public comment period provided by the
state, unless the petitioner demonstrates
that it was impracticable to raise issues
during the comment period, or the
grounds for the issues arose after this
period.
On September 3, 2008, EPA received
a petition from the Sierra Club
requesting that EPA object to the Title
V operating permit for Columbia. The
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
57313
Petitioner alleges that the permit is not
in compliance with the requirements of
the Act. Specifically, the Petitioner
alleges that: (1) Certain projects should
have been subject to the prevention of
significant deterioration program; (2)
Wisconsin did not adequately respond
to comments on the draft permit; (3) a
schedule of compliance should have
been included for opacity violations;
and, (4) a case-by-case maximum
achievable control technology standard
should have been included in the
permit.
On October 8, 2009, the Administrator
issued an order granting the Columbia
petition in part, and denying it in part.
The order explains the reasons behind
EPA’s conclusion.
Dated: October 26, 2009.
Richard C. Karl,
Acting Regional Administrator, Region 5.
[FR Doc. E9–26697 Filed 11–4–09; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[FRL–8977–6; Docket ID No. EPA–HQ–ORD–
2009–0217]
Draft Toxicological Review of
Chloroprene: In Support of the
Summary Information in the Integrated
Risk Information System (IRIS)
AGENCY: Environmental Protection
Agency (EPA).
ACTION: Notice of listening session.
SUMMARY: EPA is announcing a listening
session to be held on November 23,
2009, during the public comment period
for the external review draft document
entitled, ‘‘Toxicological Review of
Choroprene: In Support of Summary
Information on the Integrated Risk
Information System (IRIS).’’ The
purpose of the listening session is to
allow all interested parties to present
scientific and technical comments on
draft IRIS health assessments to EPA
and other interested parties during the
public comment period and prior to the
external peer review meeting. EPA
welcomes the scientific and technical
comments that will be provided to the
Agency by the listening session
participants. The comments will be
considered by the Agency as it revises
the draft assessment in response to the
independent external peer review and
public comments. All presentations will
become part of the official and public
record.
The EPA’s draft assessment and peer
review charge are available via the
Internet on the National Center for
E:\FR\FM\05NON1.SGM
05NON1
57314
Federal Register / Vol. 74, No. 213 / Thursday, November 5, 2009 / Notices
erowe on DSK5CLS3C1PROD with NOTICES
Environmental Assessment’s (NCEA)
home page under the Recent Additions
and Publications menus at https://
www.epa.gov/ncea.
DATES: The listening session on the draft
IRIS health assessment for chloroprene
will be held on November 23, 2009,
beginning at 9 a.m. and ending at 4
p.m., Eastern Standard Time. If you
wish to make a presentation at the
listening session, you should register by
November 16, 2009, indicate that you
wish to make oral comments at the
session, and indicate the length of your
presentation. At the time of your
registration, please indicate if you
require audio-visual aid (e.g., lap top
and slide projector). In general, each
presentation should be no more than 30
minutes. If, however, there are more
requests for presentations than the
allotted time will allow, then the time
limit for each presentation will be
adjusted accordingly. A copy of the
agenda for the listening session will be
available at the meeting. If no speakers
have registered by November 16, 2009,
the listening session will be cancelled.
EPA will notify those registered to
attend of the cancellation.
The public comment period for
review of this draft assessment was
announced previously in the Federal
Register (FR) (74 FR 49874) on
September 29, 2009. As stated in that FR
notice, the public comment period
began on September 29, 2009, and ends
November 30, 2009. Any technical
comments submitted during the public
comment period should be in writing
and must be received by EPA by
November 30, 2009, according to the
procedures outlined below. Only those
public comments submitted using the
procedures identified in the September
29, 2009, FR notice by the November 30,
2009, deadline will be provided to the
independent peer-review panel prior to
the peer-review meeting. The date and
logistics for the peer-review meeting
will be announced later in a separate FR
notice.
Listening session participants who
wish to have their comments available
to the external peer reviewers should
also submit written comments during
the public comment period using the
detailed and established procedures
included in the aforementioned
September 29, 2009, FR notice (74 FR
49874). Comments submitted to the
docket prior to the end of the public
comment period will be submitted to
the external peer reviewers and
considered by EPA in the disposition of
public comments. Comments received
in the docket after the public comment
VerDate Nov<24>2008
14:57 Nov 04, 2009
Jkt 220001
period closes will not be submitted to
the external peer reviewers.
ADDRESSES: The listening session on the
draft chloroprene assessment will be
held at the EPA offices at Two Potomac
Yard (North Building), 7th Floor, Room
7100, 2733 South Crystal Drive,
Arlington, Virginia 22202. To attend the
listening session, please register by
November 16, 2009, by contacting Ms.
Karie Riley, of Versar, Inc, by e-mail at
KRiley@versar.com (subject line:
Chloroprene Listening Session), or by
phone: (703) 750–3000, ext. 579 or toll
free at 1–800–2–VERSAR (1–800–283–
7727), ext. 579. Ask for the Chloroprene
Listening Session Coordinator, Karie
Riley. Please note that to gain entrance
to this EPA building to attend the
meeting, attendees must have photo
identification with them and must
register at the guard’s desk in the lobby.
The guard will retain your photo
identification and will provide you with
a visitor’s badge. At the guard’s desk,
attendees should give the name
Christine Ross and the telephone
number, 703–347–8592, to the guard on
duty. The guard will contact Ms. Ross
who will meet you in the reception area
to escort you to the meeting room. Upon
your exit from the building please
return your visitor’s badge and you will
receive the photo identification that you
provided.
A teleconference line will also be
available for registered attendees/
speakers. The teleconference number is
866–299–3188 and the access code is
926–378–7897 followed by the pound
sign (#). The teleconference line will be
activated at 8:45 am, and you will be
asked to identify yourself and your
affiliation at the beginning of the call.
Information on Services for
Individuals with Disabilities: EPA
welcomes the attendance of the public
at the ‘‘Chloroprene Listening Session’’
and will make every effort to
accommodate persons with disabilities.
For information on access or services for
individuals with disabilities, please
contact Christine Ross at 703–347–8592
or ross.christine@epa.gov. To request
accommodation of a disability, please
contact Ms. Ross, preferably at least 10
days prior to the meeting, to give EPA
as much time as possible to process
your request.
FOR FURTHER INFORMATION CONTACT: For
information on the public listening
sessions, please contact Christine Ross,
IRIS Staff, National Center for
Environmental Assessment, (8601P),
U.S. EPA, 1200 Pennsylvania Avenue,
NW., Washington, DC 20460; telephone:
703–347–8592; facsimile: 703–347–
8689; or e-mail: ross.christine@epa.gov.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
If you have questions about the draft
chloroprene assessment, contact Allen
Davis, IRIS Staff, National Center for
Environmental Assessment, U.S. EPA,
109 T.W. Alexander Drive, B243–01,
Durham, NC 27711; telephone: 919–
541–3789; facsimile: 919–541–0245; or
e-mail: davis.allen@epa.gov.
SUPPLEMENTARY INFORMATION: IRIS is a
database that contains potential adverse
human health effects information that
may result from chronic (or lifetime)
exposure to specific chemical
substances found in the environment.
The database (available on the Internet
at https://www.epa.gov/iris) contains
qualitative and quantitative health
effects information for more than 540
chemical substances that may be used to
support the first two steps (hazard
identification and dose-response
evaluation) of a risk assessment process.
When supported by available data, the
database provides oral reference doses
(RfDs) and inhalation reference
concentrations (RfCs) for chronic health
effects, and oral slope factors and
inhalation unit risks for carcinogenic
effects. Combined with specific
exposure information, government and
private entities can use IRIS data to help
characterize public health risks of
chemical substances in a site-specific
situation and thereby support risk
management decisions designed to
protect public health.
Dated: October 27, 2009.
Peter W. Preuss,
Director, National Center for Environmental
Assessment.
[FR Doc. E9–26692 Filed 11–4–09; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL MINE SAFETY AND HEALTH
REVIEW COMMISSION
Sunshine Act Meeting Notice
October 30, 2009.
TIME AND DATE: 10 a.m., Thursday,
November 12, 2009.
PLACE: The Richard V. Backley Hearing
Room, 9th Floor, 601 New Jersey
Avenue, NW., Washington, DC.
STATUS: Open.
MATTERS TO BE CONSIDERED: The
Commission will consider and act upon
the following in open session: Secretary
of Labor v. Coal River Mining, LLC,
Docket No. WEVA 2006–125–R, et al.
(Issues include whether the
Administrative Law Judge erred in
finding that a violation of 30 CFR
75.340(a) was not attributable to the
operator’s unwarrantable failure, and
whether the Judge erred in reducing the
E:\FR\FM\05NON1.SGM
05NON1
Agencies
[Federal Register Volume 74, Number 213 (Thursday, November 5, 2009)]
[Notices]
[Pages 57313-57314]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-26692]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[FRL-8977-6; Docket ID No. EPA-HQ-ORD-2009-0217]
Draft Toxicological Review of Chloroprene: In Support of the
Summary Information in the Integrated Risk Information System (IRIS)
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice of listening session.
-----------------------------------------------------------------------
SUMMARY: EPA is announcing a listening session to be held on November
23, 2009, during the public comment period for the external review
draft document entitled, ``Toxicological Review of Choroprene: In
Support of Summary Information on the Integrated Risk Information
System (IRIS).'' The purpose of the listening session is to allow all
interested parties to present scientific and technical comments on
draft IRIS health assessments to EPA and other interested parties
during the public comment period and prior to the external peer review
meeting. EPA welcomes the scientific and technical comments that will
be provided to the Agency by the listening session participants. The
comments will be considered by the Agency as it revises the draft
assessment in response to the independent external peer review and
public comments. All presentations will become part of the official and
public record.
The EPA's draft assessment and peer review charge are available via
the Internet on the National Center for
[[Page 57314]]
Environmental Assessment's (NCEA) home page under the Recent Additions
and Publications menus at https://www.epa.gov/ncea.
DATES: The listening session on the draft IRIS health assessment for
chloroprene will be held on November 23, 2009, beginning at 9 a.m. and
ending at 4 p.m., Eastern Standard Time. If you wish to make a
presentation at the listening session, you should register by November
16, 2009, indicate that you wish to make oral comments at the session,
and indicate the length of your presentation. At the time of your
registration, please indicate if you require audio-visual aid (e.g.,
lap top and slide projector). In general, each presentation should be
no more than 30 minutes. If, however, there are more requests for
presentations than the allotted time will allow, then the time limit
for each presentation will be adjusted accordingly. A copy of the
agenda for the listening session will be available at the meeting. If
no speakers have registered by November 16, 2009, the listening session
will be cancelled. EPA will notify those registered to attend of the
cancellation.
The public comment period for review of this draft assessment was
announced previously in the Federal Register (FR) (74 FR 49874) on
September 29, 2009. As stated in that FR notice, the public comment
period began on September 29, 2009, and ends November 30, 2009. Any
technical comments submitted during the public comment period should be
in writing and must be received by EPA by November 30, 2009, according
to the procedures outlined below. Only those public comments submitted
using the procedures identified in the September 29, 2009, FR notice by
the November 30, 2009, deadline will be provided to the independent
peer-review panel prior to the peer-review meeting. The date and
logistics for the peer-review meeting will be announced later in a
separate FR notice.
Listening session participants who wish to have their comments
available to the external peer reviewers should also submit written
comments during the public comment period using the detailed and
established procedures included in the aforementioned September 29,
2009, FR notice (74 FR 49874). Comments submitted to the docket prior
to the end of the public comment period will be submitted to the
external peer reviewers and considered by EPA in the disposition of
public comments. Comments received in the docket after the public
comment period closes will not be submitted to the external peer
reviewers.
ADDRESSES: The listening session on the draft chloroprene assessment
will be held at the EPA offices at Two Potomac Yard (North Building),
7th Floor, Room 7100, 2733 South Crystal Drive, Arlington, Virginia
22202. To attend the listening session, please register by November 16,
2009, by contacting Ms. Karie Riley, of Versar, Inc, by e-mail at
KRiley@versar.com (subject line: Chloroprene Listening Session), or by
phone: (703) 750-3000, ext. 579 or toll free at 1-800-2-VERSAR (1-800-
283-7727), ext. 579. Ask for the Chloroprene Listening Session
Coordinator, Karie Riley. Please note that to gain entrance to this EPA
building to attend the meeting, attendees must have photo
identification with them and must register at the guard's desk in the
lobby. The guard will retain your photo identification and will provide
you with a visitor's badge. At the guard's desk, attendees should give
the name Christine Ross and the telephone number, 703-347-8592, to the
guard on duty. The guard will contact Ms. Ross who will meet you in the
reception area to escort you to the meeting room. Upon your exit from
the building please return your visitor's badge and you will receive
the photo identification that you provided.
A teleconference line will also be available for registered
attendees/speakers. The teleconference number is 866-299-3188 and the
access code is 926-378-7897 followed by the pound sign (). The
teleconference line will be activated at 8:45 am, and you will be asked
to identify yourself and your affiliation at the beginning of the call.
Information on Services for Individuals with Disabilities: EPA
welcomes the attendance of the public at the ``Chloroprene Listening
Session'' and will make every effort to accommodate persons with
disabilities. For information on access or services for individuals
with disabilities, please contact Christine Ross at 703-347-8592 or
ross.christine@epa.gov. To request accommodation of a disability,
please contact Ms. Ross, preferably at least 10 days prior to the
meeting, to give EPA as much time as possible to process your request.
FOR FURTHER INFORMATION CONTACT: For information on the public
listening sessions, please contact Christine Ross, IRIS Staff, National
Center for Environmental Assessment, (8601P), U.S. EPA, 1200
Pennsylvania Avenue, NW., Washington, DC 20460; telephone: 703-347-
8592; facsimile: 703-347-8689; or e-mail: ross.christine@epa.gov. If
you have questions about the draft chloroprene assessment, contact
Allen Davis, IRIS Staff, National Center for Environmental Assessment,
U.S. EPA, 109 T.W. Alexander Drive, B243-01, Durham, NC 27711;
telephone: 919-541-3789; facsimile: 919-541-0245; or e-mail:
davis.allen@epa.gov.
SUPPLEMENTARY INFORMATION: IRIS is a database that contains potential
adverse human health effects information that may result from chronic
(or lifetime) exposure to specific chemical substances found in the
environment. The database (available on the Internet at https://www.epa.gov/iris) contains qualitative and quantitative health effects
information for more than 540 chemical substances that may be used to
support the first two steps (hazard identification and dose-response
evaluation) of a risk assessment process. When supported by available
data, the database provides oral reference doses (RfDs) and inhalation
reference concentrations (RfCs) for chronic health effects, and oral
slope factors and inhalation unit risks for carcinogenic effects.
Combined with specific exposure information, government and private
entities can use IRIS data to help characterize public health risks of
chemical substances in a site-specific situation and thereby support
risk management decisions designed to protect public health.
Dated: October 27, 2009.
Peter W. Preuss,
Director, National Center for Environmental Assessment.
[FR Doc. E9-26692 Filed 11-4-09; 8:45 am]
BILLING CODE 6560-50-P